Subject
Pulmonary and Respiratory Medicine,Oncology
Reference26 articles.
1. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003
2. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial;Baas;Lancet,2021
3. Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial;Pinto;Lancet Oncol,2021
4. Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesothelioma;Kim;Lung Cancer,2021
5. Immune checkpoint inhibitor uptake in real-world patients with malignant pleural mesothelioma;Kim;JTO Clin Res Rep,2021